4. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2023. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed Nov. 9, 2023.
- Pimecrolimus (Elidel) package insert. Valeant -Bausch Health, September 2020.
- Tacrolimus (Protopic) package insert. Leo Pharma Inc., June 2022.
- U.S. Department of Health and Human Services. U.S. Food and Drug Administration. FDA approves updated labeling with boxed warning and medication guide for two eczema drugs, Elidel and Protopic. (January 19, 2006) Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm153941.htm. Accessed Nov. 9, 2023.
- Ring, Johannes, et al. "The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy." Drug Safety, vol. 31, no. 3, Mar. 2008, pp. 185+. Gale OneFile: Health and Medicine, link.gale.com/apps/doc/A200506441/HRCA?u=txshracd2607&sid=bookmark-HRCA&xid=2bbaeb0b. Accessed Nov. 9, 2023.